Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Phase 2

Completed

Conditions: Non-Hodgkin's Lymphoma
Allogeneic Marrow Transplant
Leukemia
Myelodysplastic Syndrome

Interventions: Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF

First Posted Date: 2007-12-28

Last Posted Date: 2016-02-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 96

Registration Number: NCT00582933

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Physical Activity and Inactivity in Lung Cancer Survivors

Completed

Conditions: Lung Cancer Survivors

First Posted Date: 2007-12-28

Last Posted Date: 2020-02-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 188

Registration Number: NCT00582348

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Identification of New Colorectal Cancer Genes

Completed

Conditions: Colorectal Cancer

First Posted Date: 2007-12-28

Last Posted Date: 2021-12-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 337

Registration Number: NCT00582335

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Spectroscopy With Surface Coils and Decoupling

Phase 1

Completed

Conditions: Adrenal Cortical Cancer
Hodgkin's Disease
Ovarian Cancer
Breast Cancer
Kaposi's Sarcoma
Lung Cancer
Renal Cancer
Sarcoma
Colon Cancer
Rectal Cancer

Interventions: Device: Proton-decoupled 31P MRS at 1.5T
Device: 1H Spectroscopy at 1.5T and 3T

First Posted Date: 2007-12-28

Last Posted Date: 2015-12-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 582

Registration Number: NCT00581815

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Phase 1

Completed

Conditions: Osseous Lesions From Metastatic Breast Cancer

First Posted Date: 2007-12-28

Last Posted Date: 2015-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT00582920

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer

Completed

Conditions: Nonmuscle Invasive Bladder Cancer
Urinary Cancer
Bladder Cancer

Interventions: Genetic: specimen samples
Behavioral: questionnaires

First Posted Date: 2007-12-28

Last Posted Date: 2015-12-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 116

Registration Number: NCT00582387

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity

Completed

Conditions: Cancer of the Oral Cavity

Interventions: Behavioral: questionnaires

First Posted Date: 2007-12-28

Last Posted Date: 2014-10-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 164

Registration Number: NCT00582413

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients

Completed

Conditions: Colorectal Cancer

Interventions: Other: Telephone survey

First Posted Date: 2007-12-28

Last Posted Date: 2009-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT00582452

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9

Not Applicable

Terminated

Conditions: Sarcoma
Neuroblastoma
CNS Cancer

Interventions: Drug: 131I-8H9
Drug: 8H9

First Posted Date: 2007-12-28

Last Posted Date: 2017-03-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT00582608

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Men Undergoing Radical Prostatectomy

Completed

Conditions: Prostate Cancer

Interventions: Other: Whole Blood Draw

First Posted Date: 2007-12-28

Last Posted Date: 2022-06-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 513

Registration Number: NCT00582530

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy